In addition, the phosphorylation of STAT3 and AKT via JAK2/STAT and PI3K/AKT signaling pathways has led immunohistochemical studies to reveal high expressions of LEPR, p-STAT3, and p-AKT in many DLBCL cases [201]. This evidence concerns the gene STAT3 and diffuse large B-cell lymphoma.